Financial information

Summary of consolidated income statement
(Unit : one million won, as of K-IFRS consolidated financial statements )
Category 2022 2023 2024 2025
Sales revenue 684,351 748,527 719,376 775,298
Operating Income 62,961 100,304 82,488 94,461
Net Income 29,853 38,430 65,040 61,511
Total Comprehensive Income 34,809 35,492 119,220 60,491
EPS 1,331(Won) 1,504(Won) 2,543(Won) 2,534(Won)
Summary of separate income statement
(Unit : one million won, as of K-IFRS separate financial statements )
Category 2022 2023 2024 2025
Sales revenue 676,887 741,063 710,599 767,150
Operating Income 67,191 104,994 81,787 96,630
Net income 34,219 39,641 63,095 61,310
Total Comprehensive Income 40,214 35,348 117,267 -
EPS 1,400(Won) 1,611(Won) 2,462(Won) 2,526(Won)

Copyright © JW Pharmaceutical,. All rights reserved